vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与Proto Labs Inc（PRLB）财务数据对比。点击上方公司名可切换其他公司
Proto Labs Inc的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.8倍（$139.3M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 10.4%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 5.3%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
Proto Labs是一家提供快速制造服务的企业，可通过3D打印、CNC加工、钣金加工以及注塑成型工艺，为客户生产用于原型制作和量产的定制零部件，产品广泛应用于医疗设备、航空航天、电子、家电、汽车、消费品等多个领域，公司总部位于美国明尼苏达州，在美国多地设有生产基地。
PBYI vs PRLB — 直观对比
营收规模更大
PRLB
是对方的1.8倍
$75.5M
营收增速更快
PBYI
高出17.3%
10.4%
两年增速更快
PBYI
近两年复合增速
5.3%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $139.3M |
| 净利润 | — | $8.1M |
| 毛利率 | 69.3% | 45.6% |
| 营业利润率 | 22.7% | 7.1% |
| 净利率 | — | 5.8% |
| 营收同比 | 27.7% | 10.4% |
| 净利润同比 | — | 125.4% |
| 每股收益（稀释后） | $0.26 | $0.29 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIPRLB
| Q1 26 | — | $139.3M | ||
| Q4 25 | $75.5M | $136.5M | ||
| Q3 25 | $54.5M | $135.4M | ||
| Q2 25 | $52.4M | $135.1M | ||
| Q1 25 | $46.0M | $126.2M | ||
| Q4 24 | $59.1M | $121.8M | ||
| Q3 24 | $80.5M | $125.6M | ||
| Q2 24 | $47.1M | $125.6M |
净利润PBYIPRLB
| Q1 26 | — | $8.1M | ||
| Q4 25 | — | — | ||
| Q3 25 | $8.8M | $7.2M | ||
| Q2 25 | $5.9M | $4.4M | ||
| Q1 25 | $3.0M | $3.6M | ||
| Q4 24 | — | — | ||
| Q3 24 | $20.3M | $7.2M | ||
| Q2 24 | $-4.5M | $4.5M |
毛利率PBYIPRLB
| Q1 26 | — | 45.6% | ||
| Q4 25 | 69.3% | 44.2% | ||
| Q3 25 | 77.7% | 45.3% | ||
| Q2 25 | 76.5% | 44.3% | ||
| Q1 25 | 77.1% | 44.1% | ||
| Q4 24 | 76.4% | 42.7% | ||
| Q3 24 | 63.9% | 45.6% | ||
| Q2 24 | 77.4% | 45.0% |
营业利润率PBYIPRLB
| Q1 26 | — | 7.1% | ||
| Q4 25 | 22.7% | 5.0% | ||
| Q3 25 | 17.6% | 6.5% | ||
| Q2 25 | 12.7% | 3.7% | ||
| Q1 25 | 8.7% | 3.6% | ||
| Q4 24 | 22.6% | -1.2% | ||
| Q3 24 | 27.4% | 6.8% | ||
| Q2 24 | -4.6% | 4.8% |
净利率PBYIPRLB
| Q1 26 | — | 5.8% | ||
| Q4 25 | — | — | ||
| Q3 25 | 16.2% | 5.3% | ||
| Q2 25 | 11.2% | 3.3% | ||
| Q1 25 | 6.5% | 2.9% | ||
| Q4 24 | — | — | ||
| Q3 24 | 25.2% | 5.7% | ||
| Q2 24 | -9.6% | 3.6% |
每股收益（稀释后）PBYIPRLB
| Q1 26 | — | $0.29 | ||
| Q4 25 | $0.26 | $0.25 | ||
| Q3 25 | $0.17 | $0.30 | ||
| Q2 25 | $0.12 | $0.18 | ||
| Q1 25 | $0.06 | $0.15 | ||
| Q4 24 | $0.40 | $-0.01 | ||
| Q3 24 | $0.41 | $0.29 | ||
| Q2 24 | $-0.09 | $0.18 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $124.0M |
| 总债务越低越好 | $22.7M | — |
| 股东权益账面价值 | $130.3M | $683.1M |
| 总资产 | $216.3M | $778.6M |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资PBYIPRLB
| Q1 26 | — | $124.0M | ||
| Q4 25 | $97.5M | $128.1M | ||
| Q3 25 | $94.4M | $119.2M | ||
| Q2 25 | $96.0M | $103.2M | ||
| Q1 25 | $93.2M | $96.8M | ||
| Q4 24 | $101.0M | $103.1M | ||
| Q3 24 | $96.7M | $100.5M | ||
| Q2 24 | $96.8M | $112.9M |
总债务PBYIPRLB
| Q1 26 | — | — | ||
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — |
股东权益PBYIPRLB
| Q1 26 | — | $683.1M | ||
| Q4 25 | $130.3M | $673.9M | ||
| Q3 25 | $115.3M | $664.7M | ||
| Q2 25 | $104.7M | $664.7M | ||
| Q1 25 | $97.1M | $656.8M | ||
| Q4 24 | $92.1M | $670.2M | ||
| Q3 24 | $71.1M | $680.0M | ||
| Q2 24 | $48.5M | $685.2M |
总资产PBYIPRLB
| Q1 26 | — | $778.6M | ||
| Q4 25 | $216.3M | $763.4M | ||
| Q3 25 | $202.9M | $756.9M | ||
| Q2 25 | $194.9M | $743.3M | ||
| Q1 25 | $196.2M | $737.5M | ||
| Q4 24 | $213.3M | $743.5M | ||
| Q3 24 | $220.7M | $753.8M | ||
| Q2 24 | $205.0M | $758.2M |
负债/权益比PBYIPRLB
| Q1 26 | — | — | ||
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $17.5M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | — |
| 自由现金流率自由现金流/营收 | 19.1% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | 2.16× |
| 过去12个月自由现金流最近4个季度 | $41.7M | — |
8季度趋势，按日历期对齐
经营现金流PBYIPRLB
| Q1 26 | — | $17.5M | ||
| Q4 25 | $14.4M | $16.5M | ||
| Q3 25 | $9.7M | $29.1M | ||
| Q2 25 | $14.1M | $10.6M | ||
| Q1 25 | $3.6M | $18.4M | ||
| Q4 24 | $15.6M | $17.3M | ||
| Q3 24 | $11.0M | $24.8M | ||
| Q2 24 | $1.0M | $14.4M |
自由现金流PBYIPRLB
| Q1 26 | — | — | ||
| Q4 25 | $14.4M | $8.4M | ||
| Q3 25 | $9.7M | $25.0M | ||
| Q2 25 | $14.1M | $9.1M | ||
| Q1 25 | $3.6M | $17.1M | ||
| Q4 24 | $15.6M | $16.5M | ||
| Q3 24 | $11.0M | $23.2M | ||
| Q2 24 | $1.0M | $10.2M |
自由现金流率PBYIPRLB
| Q1 26 | — | — | ||
| Q4 25 | 19.1% | 6.2% | ||
| Q3 25 | 17.7% | 18.5% | ||
| Q2 25 | 26.8% | 6.7% | ||
| Q1 25 | 7.7% | 13.6% | ||
| Q4 24 | 26.4% | 13.5% | ||
| Q3 24 | 13.7% | 18.5% | ||
| Q2 24 | 2.1% | 8.2% |
资本支出强度PBYIPRLB
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 5.9% | ||
| Q3 25 | 0.0% | 3.0% | ||
| Q2 25 | 0.0% | 1.1% | ||
| Q1 25 | 0.1% | 1.0% | ||
| Q4 24 | 0.0% | 0.7% | ||
| Q3 24 | 0.0% | 1.2% | ||
| Q2 24 | 0.0% | 3.3% |
现金转化率PBYIPRLB
| Q1 26 | — | 2.16× | ||
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | 4.03× | ||
| Q2 25 | 2.41× | 2.39× | ||
| Q1 25 | 1.21× | 5.11× | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | 3.44× | ||
| Q2 24 | — | 3.18× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
PRLB
| CNC Machining | $63.2M | 45% |
| Injection Molding | $51.1M | 37% |
| 3D Printing | $20.5M | 15% |
| Sheet Metal | $4.4M | 3% |
| Other Revenue | $207.0K | 0% |
